Off-campus UMass Amherst users: To download dissertations, please use the following link to log into our proxy server with your UMass Amherst user name and password.

Non-UMass Amherst users, please click the view more button below to purchase a copy of this dissertation from Proquest.

(Some titles may also be available free of charge in our Open Access Dissertation Collection, so please check there first.)

Inhibition of lung carcinogenesis by polymethoxyflavones

Noppawat Charoensinphon, University of Massachusetts Amherst


Lung cancer is the leading cause of cancer-related death worldwide. Exclusively found in citrus peels, the inhibitory effects of polymethoxyflavones (PMFs) on 3 human non-small cell lung cancer cells have been investigated. Results showed that monodemethylated PMFs at 5-position potently inhibited lung cancer cells than those of their permethoxylated counterparts. The inhibition of cancer cells caused by monodemethylated PMFs was associated with both extensive cell cycle arrest and apoptosis as a result of modulation of key oncogenic signaling proteins. Treatment with different bioactive compounds in combination may enhance inhibitory effects on lung cancer due to their synergistic interaction among these agents. Results showed that both nobiletin/atorvastatin (NBT/ATST) and tangeretin/atorvastatin (TAN/ATST) co-treatments at low doses exerted strong synergy as confirmed by isobologram analysis, and also produced much stronger inhibitory effects on lung cancer cells in comparison to those produced by NBT, TAN, or ATST alone at higher doses. Flow cytometry analysis showed both NBT/ATST and TAN/ATST co-treatments significantly induced cell cycle arrest and apoptosis, and these molecular events were involved with prenylation of RhoA which subsequently resulted in alteration of key signaling proteins. Supplementation of mevalonate or geranylgeranyl pyrophosphate significantly counteracted the effects caused by NBT/ATST. Inhibitory effects of metabolites of PMFs against lung cancer cells were significantly stronger than those produced by their parental compounds. Treatments of PMFs significantly inhibited lung tumorsphere formation and aldehyde dehydrogenase bright cells implicating the potential utilization of these compounds to target lung cancer stem cells.

Subject Area

Molecular biology|Food Science|Pharmacy sciences|Oncology

Recommended Citation

Charoensinphon, Noppawat, "Inhibition of lung carcinogenesis by polymethoxyflavones" (2013). Doctoral Dissertations Available from Proquest. AAI3603063.